Drug combination reaches key threshold for ‘functional cure’ of chronic liver infection that affects more than 250 million ...

A groundbreaking surgical technique enabled a 61-year-old patient suffering from advanced liver cancer to regenerate his ...

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B ...

It's your body's built-in cleansing system, but medical experts share possible signs your liver needs detoxing help.

Chronic hepatitis C infections have fallen in people who inject drugs in the last 6 years. The latest data from the UK Health ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, ...

As the end of the year approaches, drinking more often than usual, such as dinners and gatherings, often leads to heavy drinking. Excessive drinking harms l ...

Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.

Aligos Therapeutics focuses on ALG-000184 for CHB and ALG-055009 for MASH, targeting large, underserved markets with growing ...

Two Boston-area biotechs are shedding staff and merging together to form a new genetic medicines company. | Chroma Medicines ...

The Model for End-Stage Liver Disease (MELD) score has played a pivotal role in assessing the severity of liver disease and prioritizing liver ...